Literature DB >> 30383205

Maximum Reading Speed in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration.

Rohit Varma1, Eric H Souied2, Adnan Tufail3, Elizabeth Tschosik4, Daniela Ferrara4, Jiameng Zhang4, David Silverman5, Chantal Dolan6, Neil M Bressler7.   

Abstract

Purpose: Geographic atrophy (GA) is an advanced form of age-related macular degeneration. GA often initially spares the center of the fovea, leading to a functional disconnect between reading speed and distance visual acuity. This study was designed to determine the correlation between baseline GA lesion size, change in lesion size, and maximum reading speed (MRS) over 18 months.
Methods: Post hoc analysis included US patients from the phase 2 Mahalo study of intravitreal lampalizumab with Minnesota low-vision reading (MNREAD) assessments at baseline and 6, 12, and 18 months. Binocular MRS was assessed using MNREAD Acuity Charts and GA lesion size by fundus autofluorescence. Correlations were estimated using Spearman's rank correlation coefficient.
Results: Seventy-seven patients were included in the analysis. Baseline MRS correlated with baseline GA lesion size (correlation coefficient, -0.47; 95% confidence interval, -0.63 to -0.28; P < 0.0001). In patients with lesions ≥10 mm2 (four disc areas), the proportion reading below a nonfluent level (MRS, <40 words/min) at baseline (26.5%) increased to 64.7% by 18 months, versus patients with lesions <10 mm2 (baseline, 9.3%; 18 months, 7.0%). MRS declined by a median of 40.9% (interquartile range [IQR], -70.2 to -6.9) in patients with ≥2.5 mm2 lesion growth versus 8.2% (IQR, -34.6 to 11.0) in patients with <2.5 mm2 lesion growth from baseline to 18 months. Conclusions: These findings suggest that baseline GA lesion size and magnitude of lesion growth are associated with a decline in MRS over time and support the use of MRS as an evaluation of functional vision in patients with GA.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30383205     DOI: 10.1167/iovs.18-24238

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  2 in total

Review 1.  Complement Mediators in Development to Treat Age-Related Macular Degeneration.

Authors:  Marcella Nebbioso; Federica Franzone; Alessandro Lambiase; Samanta Taurone; Marco Artico; Magda Gharbiya; Antonio Greco; Antonella Polimeni
Journal:  Drugs Aging       Date:  2022-01-20       Impact factor: 3.923

2.  Reading Performance in Blue Cone Monochromacy: Defining an Outcome Measure for a Clinical Trial.

Authors:  Evelyn P Semenov; Rebecca Sheplock; Alejandro J Roman; David B McGuigan; Malgorzata Swider; Artur V Cideciyan; Samuel G Jacobson
Journal:  Transl Vis Sci Technol       Date:  2020-12-08       Impact factor: 3.283

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.